Expert: NIH Encourages Data from Clinical Trials be Disaggregated by Sex in Reporting

Video

Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health at the National Institutes of Health, discusses how clinical trials have evolved to address biological and sociological variables in patient health.

Pharmacy Times interviewed Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health at the National Institutes of Health. Temkin was recently a keynote speaker at the Sex and Gender Health Education Summit, which looked to address the current progress to transform medical education and health care training.

During this discussion, Temkin addresses how clinical trials have evolved to address biological and sociological variables in patient health.

Related Videos
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Mayo Clinic oncology pharmacy
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.